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Skeletal muscle is the most abundant tissue in the 
body. It is composed by striated myofibers consisting of 
multinucleated syncytia deriving from proliferation and 
fusion of myogenic progenitor cells. As other terminally 
differentiated tissues, the skeletal muscle retains the ability 
to regenerate after damage, reactivating the myogenic 
process normally occurring in the embryonal and fetal life. 
Indeed, in postnatal skeletal muscle, a fraction of myogenic 
progenitors, namely satellite cells, remains quiescent in 
close proximity to myofiber basal membrane, ready to 
be reactivated in case of need. Despite such regenerative 
ability, however, altered muscle homeostasis is a frequent 
feature in both physiological (e.g., aging) and pathological 
states, such as muscle dystrophies, cancer, diabetes and 
neuromuscular diseases. As a result, the quality of life 
is severely compromised, rendering difficult to perform 
normal daily activities as well as impairing both tolerance 
and effectiveness of therapeutic regimens. 
The most frequent alteration occurring in the skeletal 
muscle in aging as well as in different pathological 
conditions is a marked depletion of structural proteins that 
eventually leads to profound atrophy. The mechanisms 
underlying such wasting phenotype are not totally 
elucidated. Several studies have clearly demonstrated that 
protein turnover rates are poised towards a hypercatabolic 
setting, that can be associated or not with reduced protein 
synthesis. While this is a constant finding in muscle 
wasting, a number of reports have shown that also impaired 
myogenesis can play a role (1). This is quite obvious 
in pathologies associated with muscle damage, such as 
Duchenne muscle dystrophy (DMD). It was a bit surprising 
to observe impairment in both myogenesis and regenerative 
response in aging-related sarcopenia and in pathologies that 
are not typically characterized by myofiber damage, such as 
diabetes and cancer (1).
Adult myogenesis is a tightly regulated process that is 
typically activated by myofiber injury. When this occurs, 
satellite cells are recruited to proliferate and differentiate 
in order to generate new myofibers or to fuse with the 
still existing ones, a process defined muscle regeneration. 
Such regenerative potential resembles the formation 
of multinucleated myofibers during the first steps of 
organogenesis and is associated with the timely expression 
of regulatory factors. Among these, Pax7 and myogenin 
show a sort of reciprocal regulation, the former being highly 
expressed in proliferating satellite cells, the latter being a 
marker of differentiation (2). In addition to satellite cells, 
other cell types can contribute to myogenesis, such as PW1+/
PAX7− interstitial cells (PICs) or mesoangioblasts (1). 
While the broad regulation of myogenesis is well known, 
the mechanisms underlying its activation and completion, 
especially in pathological states, are not totally clear. In this 
regard, evidence has been provided that noncoding RNAs, 
in particular microRNAs (miRs) and long noncoding RNAs 
(lncRNAs), contribute to myogenesis as well as to the 
acquisition of muscle function. Discovered in the last decade 
of the past century, miRs are short noncoding RNAs that 
regulate gene expression targeting the 3’ untranslated region 
(UTR) of mRNAs, resulting in accelerated degradation 
of mRNA and/or inhibition of translation. MiRs have 
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been involved in several events such as cell proliferation, 
differentiation and death, DNA repair, oxidative stress 
response. Specific miRs have been indicated as muscle-
specific, or myomiRs, in view of their involvement in 
different steps of myogenesis and/or regulation of muscle 
trophism. As for lncRNAs, they are about 10 folds larger 
than miRs (about 200 and 20 nucleotides, respectively), do 
not code for proteins, and can be polyadenylated. They 
have been proposed to regulate gene expression, even if the 
underlying mechanisms are still poorly defined (3). 
A recent study by Legnini and collaborators (4) proposes 
that also circular RNAs (circRNAs) can participate in 
the regulation of myogenesis. In particular, they identify 
circ-ZNF609 as able to specifically modulate myoblast 
proliferation. 
CircRNAs are RNA molecules that lack both the 5’ 
and 3’ ends, structured as covalently closed continuous 
loops, usually generated by a back-splicing reaction. They 
are expressed by a high number of genes and appear to be 
highly conserved among species. Recently circRNAs have 
been involved in human fetal development, myocardial 
infarction and carcinogenesis. Little is known about the 
mechanism of action of circRNAs. Some studies have 
shown that they can act as miR sponges and a circRNA-
miR-mRNA axis has been proposed. CircRNAs can also 
participate in transcriptional regulation, in competition 
with linear splicing and operate protein sequestration in the 
cytoplasm. Finally, circRNAs with open reading frames can 
be translated giving rise to peptides (5).
The study by Legnini et al. (4) describes for the first 
time the circRNA profile of human and murine myocytes, 
both proliferating (myoblasts) and after differentiation to 
myotubes. As a first step, the authors performed a RNA 
sequencing (RNA-seq) analysis, revealing that the pattern of 
gene expression in myoblasts is markedly different from that 
of myotubes; in particular, genes upregulated in myotubes 
pertain to pathways associated with myogenic differentiation 
and muscle function. The authors validated by qRT-PCR 
four myogenic markers, namely MyoD, myosin heavy 
chain, muscle creatine kinase and dystrophin. Searching for 
circRNA, Legnini et al. (4) observed that they were highly 
frequent and significantly conserved between the two species 
analyzed (mice and human beings). About 90% of circRNA 
derived from internal exons of protein coding genes, and 
10% where expressed more than their linear counterpart. A 
linear correlation is reported between circRNAs and linear 
RNAs. Similar to total RNA-seq, also the expression of 
circRNA is quite different in myoblasts vs. myotubes. 
The authors also report a peculiar circRNA profile in 
myoblasts and myotubes. In particular, the abundance 
of circRNAs seems to increase in differentiated vs. non-
differentiated cells. The same pattern can be observed 
for the circular/linear RNA ratio, likely due to both the 
increased circRNA transcription rate and to its higher 
stability in comparison to linear mRNAs. CircRNA profile 
in myoblasts and myotubes derived from DMD patients is 
also different from that observed in normal cultures.
To have information about the role of some of the 
differentially expressed circRNAs, the authors adopted a 
RNA interference-based functional screening. They identified 
circ-QKI as positive regulator of myogenic differentiation, 
a function that is shared with the linear QKI mRNA. By 
contrast, circ-BNC2 appeared to stimulate myogenesis 
by competing with the production of the respective linear 
mRNA. In other words, high circ-BNC2 levels were 
associated with low linear BNC2 mRNA, suggesting that the 
role of the former is to reduce the production of the latter, 
antagonizing its anti-myogenic potential. Both circRNAs, 
whose expression is increased in normal myotubes vs. 
myoblasts, favoring differentiation, are down-regulated in 
DMD cultures. This observation is consistent with the well-
known impairment of myogenic differentiation occurring in 
the skeletal muscle of DMD patients. 
Legnini and collaborators (4) observed an opposite 
function for circ-ZNF609. It was highly expressed in 
myoblasts, and its down-regulation by specific siRNAs 
resulted in marked inhibition of myoblast proliferation, 
evaluated as reduced BrdU incorporation and decreased 
expression of CDK1 and cyclinA2. Circ-ZNF609 was highly 
expressed in DMD myocyte cultures, consistently with the 
impaired differentiation displayed by these cells. These 
results suggest the occurrence of a reciprocal regulation 
of circ-QIK/circ-BCN2 and circ-ZNF609, the former 
stimulating myogenic differentiation, the latter muscle 
progenitor expansion. However, different from circ-QIK 
and circ-BNC2, whose bioactivity derives from cooperation 
(circ-QIK) or antagonism (circ-BNC2) with their linear 
counterpart, circ-ZNF609 acts specifically on myoblast 
proliferation, without interfering with the linear mRNA. 
Since circ-ZNF609 contains a 753-nucleotide open 
reading frame, the authors investigated if it could be 
translated into a protein. The results show that circ-ZNF609 
can interact with heavy polysomes and that it can be 
effectively translated into a protein, even if the efficiency 
of translation is markedly lower than that displayed by the 
linear mRNA counterpart. CircRNAs do not have a cap 
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structure, so they can only be translated in a cap-independent 
manner. Consistently, the UTR of circ-ZNF609 acts as an 
internal ribosome entry site (IRES) in a splicing-dependent 
manner. Cap-independent translation is often up-regulated 
in condition of cell stress, to achieve rapid modulations of 
protein expression. Indeed, the results reported by Legnini 
et al. (4) show that circ-ZNF609 translation can be up-regulated 
by heat shock. Finally, circ-ZNF609 in myoblasts displays 
a high degree of methylation, suggesting an additional 
mechanism of translational regulation. 
At present the function of the protein encoded by circ-
ZNF609 is totally unknown. It might well be endowed with 
independent activity or it can be important to modulate 
the protein produced translating the linear mRNA. This 
latter protein is a transcription factor containing two zinc-
finger domains that has been reported to directly target 
the Rag1 promoter in T lymphocyte precursors during 
thymic maturation. In this regard, mutations affecting 
ZNF609 may produce immunodeficiency or autoimmune 
response (6). ZNF609 has also been shown to directly 
interact with Dax1 (7) and with Nipbl (8), contributing to 
the maintenance of embryonic stem cell pluripotency or 
regulating neuronal migration genes, respectively. Legnini 
and collaborators (4) show that the protein encoded by circ-
ZNF609 lacks the zinc-finger domains, suggesting that 
it could be a dominant-negative competitor of the native 
protein, or become an alternative partner in the ZNF609 
complex formation with other proteins (see above). 
The study by Legnini et al. (4) proposes for the first 
time that circ-ZNF609 might exert a regulatory action by 
encoding a protein. Indeed, the literature reports just one 
study showing that circ-ZNF609 regulates AKT3 expression 
in Hirschsprung disease acting as a sponge for miR-150-5p, 
thus behaving as an endogenous competitor (9). In addition, 
Legnini and collaborators (4) propose a novel mechanism 
regulating myogenesis, in both physiological and pathological 
states. At present, there are no effective treatments able to 
interfere with the development of muscle wasting. In this 
regard, understanding the mechanisms of myogenesis and 
muscle function will prove valuable for the comprehension 
of muscle-associated diseases as well as for the design of 
appropriate therapeutic strategies. The new findings by 
Legnini et al. (4) perfectly fit with this picture, providing 
cues useful to set up targeted interventions responding to the 
concept of both regenerative and precision medicine. 
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